Manuscripts & Publications

Immunogenicity of DaxibotulinumtoxinA for Injection in Facial Aesthetic Treatment.

Humphrey S., Dover J.S., Bowsher R.R., Clancy A., Prawdzik G., and Gallagher C.J.

Aesthetic Surgery Journal 2023

Noncompetitive immunoassay optimized for pharmacokinetic assessments of biologically active efruxifermin

Adam Kinne, Erik Tillman, Sanofar J. Abdeen, Derrick Johnson, Elijah Parmer, Jacob Hurst, Brittany de Temple, Sherri Rinker, Timothy Rolph, Ronald Bowsher

Journal of Pharmaceutical and Biomedical Analysis 2023

Assay development considerations to improve drug tolerance in direct competitive ligand binding neutralizing antibody assays, pretreatment strategies

Alok Rathi, Sherri Rinker, Hongmei Niu, Carina Carter, Seema Kumar, Kyra Cowen

Journal of Immunological Methods 2023

Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines Pooled Data from the SAKURA Phase 3 Trials

Conor J. Gallagher 1,*, Ronald R. Bowsher 2, Amanda Clancy 2, Jeffrey S. Dover 3, Shannon Humphrey 4, Yan Liu 1 and Gregg Prawdzik 1

Toxins 2023

Critical reagent inventory management system and web portal specifically optimized for supporting external clients

Jessica A Feauto, Aleks Davis, Sanofar J Abdeen, Hannah N Gill, Jamie E Colwell, Michael Chiappetta, Ronald R Bowsher

Bioanalysis 2022

Immunogenicity Manuscript: "An Integrated Analysis of Dostarlimab Immunogenicity"

Sharon Lu, Ronald R. Bowsher, Amanda Clancy, Amy Rosen, Mingxuan Zhang, Ying Yang, Kathleen Koeck, Minggeng Gao, Elizabeth Potocka, Wei Guo, Kai Yu Jen, Ellie Im & Ashley Milton

AAPS Journal 2021

Sensitive assay design for detection of anti-drug antibodies to biotherapeutics that lack an immunoglobulin Fc domain

Derrick Johnson, Erica Simmons, Sanofar Abdeen, Adam Kinne, Elijah Parmer, Sherri Rinker, Jennifer Thystrup, Swarna Ramaswamy & Ronald R. Bowsher

Nature Scientific Report 2021